Sahajanand Medical Technologies

The trial seeks to address the unique challenges faced by diabetic patients who are at a higher risk of adverse outcomes following…

Hydra TAVI devices gain nationwide access in Italian hospitals

Key findings reveal the Hydra THV's outstanding safety and efficacy, with a low cardiovascular mortality rate of 2.5 per cent and…

To deliver up to 40,000 of its bio degradable polymer coated DES ‘Supraflex’ stents by 2022

With the acquisition SMT has entered into structural heart segment

This acquisition will help SMT enhance its market share with increased on-ground presence, working closely with healthcare…

Being one of the most trackable stents globally, more than 2,50,000 people with coronary artery diseases have been treated with…